Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 25, 2021, titled "Zydus Cadila receives final approval from USFDA for Nortriptyline Hydrochloride Capsules".
Press Release Feb 25 2021
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 19 2021
- Press Release Feb 05 2021
- Press Release Feb 04 2021
- Press Release Jan 28 2021
- Press Release Jan 25 2021
Later from Zydus Lifesciences
- Press Release Mar 24 2021
- Press Release Mar 25 2021
- Press Release Apr 05 2021
- Press Release Apr 08 2021
- Press Release Apr 23 2021
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences